Atlas Trials

Efficacy and Safety Study of Nab-Paclitaxel Combined With Cisplatin in Second or Later-Line Treatment in Advanced Biliary Tract Cancers

Clinical trial NCT04111380 · UNKNOWN

Trial details

NCT number
NCT04111380
Sponsor
Henan Provincial People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Biliary Tract Cancers
Start date
2019-09-24
Primary completion
2023-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.